BACKGROUND: We examined the effect of kidney disease (KD) on mortality in nondiabetic and diabetic Pima Indians aged > or = 45 years old. METHODS: Deaths and person-years of follow-up were stratified in a time-dependent fashion into categories of (1) no proteinuria and normal serum creatinine (SCr); (2) proteinuria and normal SCr; (3) high SCr [SCr > or = 133 micromol/L (1.5 mg/dL) in men, > or = 124 micromol/L (1.4 mg/dL) in women] but not on renal replacement therapy (RRT); or (4) RRT. RESULTS: Among 1993 subjects, 55.8% had type 2 diabetes at baseline. Overall death rates increased with declining kidney function in both the nondiabetic and diabetic subjects (P < 0.0001). Death rates were similar in nondiabetic and diabetic subjects with comparable levels of kidney function, although the number of deaths among nondiabetic subjects with advanced KD was small. Infections and malignancy were the leading causes of death in nondiabetic subjects with KD. Among diabetic subjects, overall mortality increased with diabetes duration (P = 0.0001) and was highest in those on RRT (P < 0.0001). High SCr was associated with higher death rates from cardiovascular disease (CVD), diabetic nephropathy (DN), infections, and malignancy. CONCLUSION: Death rates increased comparably with worsening kidney function in both nondiabetic and diabetic subjects and were similar in nondiabetic and diabetic subjects without KD. KD was associated with excess mortality from DN, CVD, infections, and malignancy in diabetic subjects, and from infections in those without diabetes.
BACKGROUND: We examined the effect of kidney disease (KD) on mortality in nondiabetic and diabetic Pima Indians aged > or = 45 years old. METHODS:Deaths and person-years of follow-up were stratified in a time-dependent fashion into categories of (1) no proteinuria and normal serum creatinine (SCr); (2) proteinuria and normal SCr; (3) high SCr [SCr > or = 133 micromol/L (1.5 mg/dL) in men, > or = 124 micromol/L (1.4 mg/dL) in women] but not on renal replacement therapy (RRT); or (4) RRT. RESULTS: Among 1993 subjects, 55.8% had type 2 diabetes at baseline. Overall death rates increased with declining kidney function in both the nondiabetic and diabetic subjects (P < 0.0001). Death rates were similar in nondiabetic and diabetic subjects with comparable levels of kidney function, although the number of deaths among nondiabetic subjects with advanced KD was small. Infections and malignancy were the leading causes of death in nondiabetic subjects with KD. Among diabetic subjects, overall mortality increased with diabetes duration (P = 0.0001) and was highest in those on RRT (P < 0.0001). High SCr was associated with higher death rates from cardiovascular disease (CVD), diabetic nephropathy (DN), infections, and malignancy. CONCLUSION:Death rates increased comparably with worsening kidney function in both nondiabetic and diabetic subjects and were similar in nondiabetic and diabetic subjects without KD. KD was associated with excess mortality from DN, CVD, infections, and malignancy in diabetic subjects, and from infections in those without diabetes.
Authors: R G Nelson; M L Sievers; W C Knowler; B A Swinburn; D J Pettitt; M F Saad; I M Liebow; B V Howard; P H Bennett Journal: Circulation Date: 1990-03 Impact factor: 29.690
Authors: Q Gong; E W Gregg; J Wang; Y An; P Zhang; W Yang; H Li; H Li; Y Jiang; Y Shuai; B Zhang; J Zhang; R B Gerzoff; G Roglic; Y Hu; G Li; P H Bennett Journal: Diabetologia Date: 2010-11-03 Impact factor: 10.122
Authors: Jiaqiong Xu; Elisa T Lee; Leif E Peterson; Richard B Devereux; Everett R Rhoades; Jason G Umans; Lyle G Best; William J Howard; Jaya Paranilam; Barbara V Howard Journal: J Clin Endocrinol Metab Date: 2012-07-16 Impact factor: 5.958
Authors: Pierre-Jean Saulnier; Brad P Dieter; Stephanie K Tanamas; Sterling M McPherson; Kevin M Wheelock; William C Knowler; Helen C Looker; Rick L Meek; Robert G Nelson; Katherine R Tuttle Journal: Am J Nephrol Date: 2017-09-22 Impact factor: 3.754
Authors: Meda E Pavkov; Clinton C Mason; Peter H Bennett; Jeffrey M Curtis; William C Knowler; Robert G Nelson Journal: Diabetes Care Date: 2009-07-10 Impact factor: 17.152
Authors: Stephanie K Tanamas; Pierre-Jean Saulnier; Gudeta D Fufaa; Kevin M Wheelock; E Jennifer Weil; Robert L Hanson; William C Knowler; Peter H Bennett; Robert G Nelson Journal: Diabetes Care Date: 2016-09-09 Impact factor: 19.112
Authors: Nawar M Shara; Helaine E Resnick; Li Lu; Jiaqiong Xu; Suma Vupputuri; Barbara V Howard; Jason G Umans Journal: J Nephrol Date: 2009 May-Jun Impact factor: 3.902